The Effects of Internet-Based and Supervised Exercise Programs in People With Multiple Sclerosis

January 8, 2024 updated by: Tahire Basak Demir, Istanbul University - Cerrahpasa (IUC)

Comparison of the Effects of Internet-Based and Supervised Exercise Programs in People With Multiple Sclerosis

The main aim of this study is resarch and compare the effects of supervised exercise programs and internet-based exercise programs, which have started to benefit from their effects in recent years, known for not requiring conditions such as transportation distance, cost and time, on motor disorders and quality of life in people with multiple sclerosis (MS). This study conducting for develop a new perspective on conventional physiotherapy and rehabilitation practices. Our study will be performed in people with MS with a high EDSS score, is seen as an important contribution for the literature.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The groups were included in exercise programs of 16 sessions in total, twice a week for 8 weeks. Exercise programs will consist of warm-up, aerobic exercises, strengthening exercises, balance exercises, breathing exercises, cooling and relaxation exercises. Exercise programs will be created by the physiotherapist and arranged every 2 weeks according to the patients' conditions. Patients who do not participate in the program 2 times in a row will be excluded from the study.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosed with MS by a neurologist
  • Being between ages of 18-65
  • Not having had an attack in the last 3 months
  • The score of Expanded Disability Status Scale (EDSS) is 5.5- 7.5
  • Not participating in a another physiotherapy and rehabilitation program
  • Having internet access

Exclusion Criteria:

  • Pregnancy
  • Severe cognitive impairment that effects participating to rehabilitation
  • The cardiopulmonary disease that will prevent aerobic exercise
  • Having a major hearing and/or vision problem
  • Having a major speech disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group I
The treatment sessions will be terminated by performing relaxation exercises combined with stretching and breathing exercises.
Other: Supervised Exercise Program Group
The exercise programs will performed with the physiotherapist. The treatment programs of the patients will start with warm-up exercises and continue with aerobic exercises. Strengthening exercises will be performed in lying, sitting and standing positions. Body weight or free weight will be used for strengthening exercises. Balance exercises will be performed in sitting and standing positions and will be performed with or without support according to the patients conditions. The treatment sessions will be terminated by performing relaxation exercises combined with stretching and breathing exercises.
Other: Group II
Patients who are in the internet-based exercise program group will register cite ''https://www.telenororehab.com /'' which is web- based physiotherapy program for exercises.
Other: Internet Based Exercise Program Group

Patients who are in the internet-based exercise program group will register cite ''https://www.telenororehab.com /'' which is web- based physiotherapy program for exercises. After the first evaluation patients will be given a username and password to log in to the system.

Before starting the exercise programs, the pages on how patients can log in to the system, how they can reach the physiotherapist through the system and how they can find individual exercise programs will be shown before the study. After logging in to their own pages, patients will be able to access video-based exercise programs that have been specially prepared for them. Patients in the Internet-based exercise program group will also be given the same exercise programs as the supervised exercise program group. The entry-exit times of patients to the system and the duration of maintaining exercise programs will be controlled from the administrator section on the system.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
2 Minutes Walk Test (2MWT) (The change between the initial value and the value after 2 months will be evaluated).
Time Frame: Baseline and end of weeks 8.
This test is performed for the assessment of walking endurance. The patient is informed about the test before starting the test. The distance that a person walks along a 25-meter corridor in 2 minutes is calculated in meters. During the test, patients who have tiredness and shortness of breath can have a rest.
Baseline and end of weeks 8.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fatigue Severity Scale (FSS) (The change between the initial value and the value after 2 months will be evaluated).
Time Frame: Baseline and end of weeks 8.
It is a scale used for the evaluation of fatigue in MS patients. It consists of a total of 9 questions. A minimum of 1 and a maximum of 7 points can be scored from each question. The minimum score that can be obtained from the test is 9 the maximum score is 63. High scores mean that fatigue has increased. Validity and reliability studies have been conducted in Turkish MS patients of the FSS.
Baseline and end of weeks 8.
12 Item MS Walking Scale (MSWS- 12) (The change between the initial value and the value after 2 months will be evaluated).
Time Frame: Baseline and end of weeks 8.
It is used for evaluating walking ability in MS patients. This scale evaluates the limitations faced by MS patients in walking in the last two weeks. Situations such as loss of balance during walking, running, going up and down stairs, standing and walking, slowing down of walking are questioned. It is a Likert-type scale consisting of 12 questions. Each question score to between 1 and 5 points. The high scores indicate that the ability to walk is affected or that there is difficulty in walking.
Baseline and end of weeks 8.
Modified Falls Efficacy Scale (MFES) (The change between the initial value and the value after 2 months will be evaluated).
Time Frame: Baseline and end of weeks 8.
The MFES aims to assess the impact of a person's fear of falling on daily living activities. MFES is consist of 14 items (10 indoor and 4 outdoor activitiy) and every question can score to 0-10. Low scores indicates high fear of falling.
Baseline and end of weeks 8.
Canadian Occupational Performance Measure (COPM) (The change between the initial value and the value after 2 months will be evaluated).
Time Frame: Baseline and end of weeks 8.
COPM evaluates the activities that a person has difficulty doing in daily life between 1-10 points as activity performance and satisfaction score. At least one, up to 5 activities can be written, resulting in a total performance and satisfaction score. These scores are divided by the number of activities written, resulting in an average performance and satisfaction score. A validity and reliability study of the scale was conducted in individuals with MS.
Baseline and end of weeks 8.
Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) (The change between the initial value and the value after 2 months will be evaluated).
Time Frame: Baseline and end of weeks 8.
): It is a scale that assess the quality of life in MS patients. MusiQoL has 9 subgroups and 31 questions. During the evaluation, patients are asked to take into account their condition for the last 4 weeks. The answers to each question and the points that can be obtained; It is never/ Never (0 points), Rarely/ A little (1 point), Sometimes/ A little (2 points), Often/ A lot (3 points), Always/ Too much (4 points). The lowest score that can be taken from the scale is 0, the highest score is 124, and a high score indicates a low quality of life.
Baseline and end of weeks 8.
The Multiple Sclerosis Impact Scale (MSIS- 29) (The change between the initial value and the value after 2 months will be evaluated).
Time Frame: Baseline and end of weeks 8.
): It is a scale consisting of a total of 29 items that evaluate the consequences of symptoms and limitations caused by MS. It is a Likert type scale consisting of 5 points that evaluates the severity of symptoms such as fatigue, tremor, muscle spasm, personal care activities, sleep problems, concentration disorders. 1= having no problems at all, 2= having very few problems, 3= having moderate problems, 4= having severe problems, 5= having very severe problems. A total of at least 29 and a maximum of 145 points. A high score indicates a high amount of yeti loss.
Baseline and end of weeks 8.
Berg Balance Scale (BBS) (The change between the initial value and the value after 2 months will be evaluated).
Time Frame: Baseline and end of weeks 8.
BBS developed for the functional assessment of balance in adults. it consists of 14 divisions. Each section is scored 0 to 4 points. 0= cannot do the task, 4= does it independently. A minimum of 0 and a maximum of 56 points can be scored. Low scores indicate a balance disorder. 0-20 points indicate a balance disorder, 21-40 points indicate an acceptable balance, 41-56 points indicate the presence of a good balance. There is a validity and reliability study of the scale in MS patients.
Baseline and end of weeks 8.
5 Times Sit to Stand Test (5TSTS) (The change between the initial value and the value after 2 months will be evaluated).
Time Frame: Baseline and end of weeks 8.
The patient is asked to sit on a chair with his arms crossed in a way to hold the other shoulders. The patient is told to sit down and get up 5 times as fast as possible. The test is terminated as soon as the person's pelvic area comes into contact with the chair. Increased time indicates a disturbed balance. The test has validity in MS patients.
Baseline and end of weeks 8.
Timed 25- Foot Walk (T25- FW) (The change between the initial value and the value after 2 months will be evaluated).
Time Frame: Baseline and end of weeks 8.
It is used for the evaluation of walking speed in MS patients. the patient is asked to walk the distance of 7.62 meters (25 steps) as fast as possible. The time is calculated in seconds. The timed 25-step walking test is known as a very suitable test for evaluating walking speed in MS patients.
Baseline and end of weeks 8.
Timed Get up and Go Test (TUG) (The change between the initial value and the value after 2 months will be evaluated).
Time Frame: Baseline and end of weeks 8.
TUG used to measure the balance and functional capacities of MS patients. The patient is asked to sit on a chair and a distance of 3 meters is determined. It is requested that the patient be with a shoe that he always uses. The patient is asked to get up from the chair, walk this distance and sit in the chair again. At this time, the time is kept in seconds by the stopwatch. High test times means reduce balance and high risk of falling. Its use in individuals with MS has been shown to be reliable and valid.
Baseline and end of weeks 8.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul University - Cerrahpasa (IUC)

Investigators

  • Study Chair: Yonca ZENGINLER YAZGAN, Istanbul University-Cerrahpasa Faculty of Health Science
  • Study Chair: Murat KURTUNCU, Istanbul University Faculty of Medicine Department of Neurology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 29, 2023

Primary Completion (Estimated)

May 29, 2024

Study Completion (Estimated)

October 29, 2024

Study Registration Dates

First Submitted

January 8, 2024

First Submitted That Met QC Criteria

January 8, 2024

First Posted (Actual)

January 18, 2024

Study Record Updates

Last Update Posted (Actual)

January 18, 2024

Last Update Submitted That Met QC Criteria

January 8, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IUC2023-04

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Patient's information will not be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis

Clinical Trials on Supervised Exercise Program Group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe